FindTrial
Sign In

Efficacy of MahÄ?paiÅ?acika GhÅ?ta against KÅ«Å?maÅ?Ä?a GhÅ?ta in Attention - Deficit/Hyperactivity Disorder

Efficacy of MahÄ?paiÅ?acika GhÅ?ta against KÅ«Å?maÅ?Ä?a GhÅ?ta in Attention â??Deficit /Hyperactivity Disorder â?? A Non-Inferiority Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053180
Enrollment
22
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Sponsors

Shifa Aboobacker V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Participants satisfying the DSM 5 Diagnostic criteria for ADHD b)Participants with age group 6-12 years c)Participants fit for Å?amana SnehapÄ?na d)No discrimination of sex, religion, caste and economic status • Participants with due consent.

Exclusion criteria

Exclusion criteria: a)Intellectual Disability b)Pervasive developmental disorder c)Epilepsy and other neurological disorder d)Participants undergoing other psychopharmacological interventions

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of MahÄ?paiÅ?acika GhÅ?ta and KÅ«Å?mÄ?Å?Ä?a GhÅ?ta in the management of Attention Deficit/Hyperactivity Disorder by using Connerâ??s revised rating scale for ADHD Timepoint: 46 days—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactDr Satheesh K MDAy

VPSV Ayurveda College, Kottakkal

drsatheeshpdm@gmail.com9249993257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026